Scinvivo aims to revolutionize cancer diagnostics and care by providing medical professionals with a next-generation minimal invasive imaging platform that enables real-time imaging of tissue structure below the surface, with incredible resolution, and combined with AI for powerful diagnosis tool and photonics-based localization for robotic surgery.

Marijn van Os

Scinvivo

Henderson Group operates multiple companies including Henderson Wholesale, Henderson Retail, and Henderson Technology, providing various services in the retail and wholesale sectors. The company is self-described as career-oriented and focused on community engagement.

Henderson Group

Scinvivo enables optical biopsy for bladder cancer diagnostics.

Current imaging techniques for bladder cancer have their limitations, as they only enable the urologist to visualise the bladder wall surface. In 30% of the cases, healthy tissue is incorrectly classified as cancerous. Another limitation is that it is difficult to fully remove a tumor during a surgical procedure, as the borders of the tumor are difficult to visualize. The last limitation is that it is impossible to determine the invasion depth of the tumor with current imaging technologies, while the invasion depth has major impact on the proposed treatment.

All these limitation lead to unnecessary, invasive, and costly interventions. 

Scinvivos technology enables the urologist to improve diagnosis, and thus decreasing the amount of interventions, patient burden, and costs.

Metric
Company Name	Scinvivo	Henderson Group
Symbol
MSH ID	COM:SCINVIVO	COM:HENDERSON-GROUP
Market	PRIVATE	PRIVATE
Sector	Healthcare	Consumer Services
Industry	Medical Devices	Retail
Country	NL	GB
Stage
Employee Count	8
Website	scinvivo.com	henderson-group.com
LinkedIn	scinvivo
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:SCINVIVO

Scinvivo

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue